Results 291 to 300 of about 2,931,663 (352)
Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients. [PDF]
Campitiello R +6 more
europepmc +1 more source
A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus. [PDF]
Renaudineau Y +12 more
europepmc +1 more source
Pyruvate kinase M2 is elevated in systemic sclerosis and plays a role in its pathogenesis. [PDF]
Steadman T, O'Reilly S.
europepmc +1 more source
Systemic sclerosis is a complex autoimmune disease characterized by a chronic and frequently progressive course and by extensive patient-to-patient variability. Like other autoimmune diseases, systemic sclerosis occurs more frequently in women, with a peak of onset in the fifth decade of life.
Maria Trojanowska, Robert Simms
exaly +8 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2022
Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue disease. Once considered an untreatable and unpredictable condition, research advancements have improved our understanding of its disease pathogenesis and ...
E. Volkmann, K. Andréasson, V. Smith
semanticscholar +1 more source
Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue disease. Once considered an untreatable and unpredictable condition, research advancements have improved our understanding of its disease pathogenesis and ...
E. Volkmann, K. Andréasson, V. Smith
semanticscholar +1 more source
T cell abnormalities in systemic sclerosis.
Autoimmunity Reviews, 2022Systemic sclerosis (SSc) is an autoimmune disease with a poor prognosis. To date, the pathogenesis of SSc is still unclear; moreover, its pathological conditions include microvascular damage, inflammation, and immune abnormalities.
Wei Jin, Yan Zheng, Ping Zhu
semanticscholar +1 more source

